ALTERNATE DAY TREATMENT AND LATE EFFECTS - THE CONCEPT OF AN EFFECTIVE DOSE PER FRACTION

被引:6
作者
COURDI, A
HERY, M
GABILLAT, JM
机构
[1] Centre A. Lacassagne, 06054 Nice Cedex
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1990年 / 19卷 / 05期
关键词
Alternate treatment; Dose per fraction; Late effects; Sclerosis;
D O I
10.1016/0360-3016(90)90235-C
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although most institutions treat all fields each day, some radiotherapists continue to adopt an alternate day schedule. The resulting daily variations of the dose per fraction in laterally located targets have been analyzed using the linear-quadratic model. Patients with breast carcinoma treated with definitive radiotherapy in 1974-1975 with one field a day were studied. An effective dose per fraction was derived, with a value higher than the average dose per fraction received by the reference point. The greater the fluctuations between the doses per fraction on successive days, the higher the effective dose per fraction. The corresponding cell survival due to alternate treatment as compared to survival with daily treatment depends on the α β ratio. For a late effect with low α β ratio, an alternate treatment may lead to almost 10-fold increase in cell kill in these lateral targets such as those responsible for subcutaneous sclerosis as compared to daily treatment of all fields with the same total dose. Taking the average effective dose per fraction in our series, the increase in cell kill was 4-fold. Acute effects would suffer less damage due to alternate treatment because of a high α β ratio. Treatment on an alternate schedule should be restricted to palliative radiotherapy. © 1990.
引用
收藏
页码:1225 / 1228
页数:4
相关论文
共 8 条
[1]   SOME METHODOLOGICAL PROBLEMS IN ESTIMATING RADIOBIOLOGICAL PARAMETERS FROM CLINICAL-DATA - ALPHA-BETA RATIOS AND ELECTRON RBE FOR CUTANEOUS REACTIONS IN PATIENTS TREATED WITH POSTMASTECTOMY RADIOTHERAPY [J].
BENTZEN, SM ;
CHRISTENSEN, JJ ;
OVERGAARD, J ;
OVERGAARD, M .
ACTA ONCOLOGICA, 1988, 27 (02) :105-116
[2]   LATENT-TIME ESTIMATION FOR LATE CUTANEOUS AND SUBCUTANEOUS RADIATION REACTIONS IN A SINGLE-FOLLOW-UP CLINICAL-STUDY [J].
BENTZEN, SM ;
THAMES, HD ;
OVERGAARD, M .
RADIOTHERAPY AND ONCOLOGY, 1989, 15 (03) :267-274
[3]  
COX JD, 1985, CANCER-AM CANCER SOC, V55, P2105, DOI 10.1002/1097-0142(19850501)55:9+<2105::AID-CNCR2820551412>3.0.CO
[4]  
2-T
[5]  
FOWLER JF, 1984, BRIT J CANCER, V49, P285
[6]   CHANGES IN EARLY AND LATE RADIATION RESPONSES WITH ALTERED DOSE FRACTIONATION - IMPLICATIONS FOR DOSE-SURVIVAL RELATIONSHIPS [J].
THAMES, HD ;
WITHERS, HR ;
PETERS, LJ ;
FLETCHER, GH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (02) :219-226
[7]  
TURESSON I, 1984, INT J RADIAT ONCOL, V10, P593, DOI 10.1016/0360-3016(84)90289-X
[8]   REPAIR CAPACITY AND KINETICS OF HUMAN-SKIN DURING FRACTIONATED RADIOTHERAPY - ERYTHEMA, DESQUAMATION, AND TELANGIECTASIA AFTER 3 AND 5 YEARS FOLLOW-UP [J].
TURESSON, I ;
THAMES, HD .
RADIOTHERAPY AND ONCOLOGY, 1989, 15 (02) :169-188